Mark Therapeutics, Inc.

Biotechnology company · Hingham, Massachusetts, United States

Mark Therapeutics, Inc. is a biotechnology company headquartered in Hingham, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $686,284 in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Mark Therapeutics at a glance

Typebiotechnology company

HeadquartersHingham, Massachusetts, United States

Employees (self-reported, 2024)1

What does Mark Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $686,284 in total (2024). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Frequently asked questions about Mark Therapeutics

Where is Mark Therapeutics headquartered?

Mark Therapeutics, Inc. is headquartered in Hingham, Massachusetts, United States.

What does Mark Therapeutics do?

Mark Therapeutics, Inc. is a biotechnology company.

Similar companies

Sunflower Therapeutics, PBCHingham, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences